2. Academic Validation
  3. Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors

Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors

  • Bioorg Med Chem Lett. 2011 Apr 15;21(8):2305-8. doi: 10.1016/j.bmcl.2011.02.085.
Cristina Rossi 1,  Marina Porcelloni,  Piero D'Andrea,  Christopher I Fincham,  Alessandro Ettorre,  Sandro Mauro,  Antonella Squarcia,  Mario Bigioni,  Massimo Parlani,  Federica Nardelli,  Monica Binaschi,  Carlo A Maggi,  Daniela Fattori
Affiliations

Affiliation

  • 1 Menarini Ricerche Pomezia, via Tito Speri 10, 00040 Pomezia, Rome, Italy.
PMID: 21420859 DOI: 10.1016/j.bmcl.2011.02.085
Abstract

We report here the strategy used in our research group to find a new class of histone deacetylase (HDAC) inhibitors. A series of N-substituted 4-alkylpiperazine and 4-alkylpiperidine hydroxamic acids, corresponding to the basic structure of HDAC inhibitors (zinc binding moiety-linker-capping group) has been designed, prepared, and tested for HDAC inhibition. Linker length and aromatic capping group connection were systematically varied to find the optimal geometric parameters. A new series of submicromolar inhibitors was thus identified, which showed antiproliferative activity on HCT-116 colon carcinoma cells.

Figures
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z